Delivery Order SPE2DB20D3104-SPE2DB22FV6V5
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,399.49 firm fixed-price delivery order is for the supply of Albendazole 200 mg tablets. The contract has an ultimate completion date of June 24, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical valued at $1,265.76. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply Albendazole 200 mg tablets. The contract has a period of performance through September 25, 2024 and is a firm fixed price agreement. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Albendazole 200 mg tablets. The contract has a ceiling value of $7,661.75 and a completion date of December 8, 2023. This delivery order contract is a firm fixed-price arrangement and is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Albendazole Tablets. The contract has a ceiling value of $5,322.71 and an ultimate completion date of December 28, 2023. Amerisourcebergen Drug Corp is the prime contractor and has received this award as part of a larger indefinite delivery contract (IDC) valued up to...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Albendazole 200 mg tablets. The contract, valued at $1,997.46, has a performance period through January 16, 2025 and was awarded on a Firm Fixed Price basis. This Delivery Order contract is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award, valued at $3,803.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,567,844,545 tablets of Albendazole 200 mg, a medication used to treat certain parasitic infections. The contract has a firm fixed price and an ultimate completion date of April 9, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award, valued at $5,633.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Albendazole 200mg tablets, a medication used to treat certain parasitic infections. The contract has a firm fixed-price pricing type and an ultimate completion date of May 12, 2025. Amerisourcebergen Drug Corp is the prime contractor for this...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Albendazole tablets. The $5,258.40 contract has an ultimate completion date of March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,371.85, is for the delivery of Albendazole 200 mg tablets to support federal medical programs. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the large pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $1,982.40, is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of May 29, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to provide 4,564,731,176 Albendazole 200 mg tablets. This appears to be part of a larger...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB22FV6V5Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Albendazole 200 mg tablets. The contract, valued at $3,145.64, is a firm fixed-price delivery order with a completion date of May 12, 2022. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 5/11/22 |